메뉴 건너뛰기




Volumn 6, Issue 4, 2001, Pages 171-172

Combined modality staging for clinically localized adenocarcinoma of the prostate as the basis for patient selection for randomized trials of neoadjuvant chemotherapy

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

EID: 0034966525     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(01)00126-0     Document Type: Article
Times cited : (8)

References (6)
  • 1
    • 0033948963 scopus 로고    scopus 로고
    • Ability of the 1992 and 1997 American Joint Commission on Cancer staging systems for prostate cancer to predict progression free survival after radial prostatectomy for stage T2 disease
    • (2000) J Urol , vol.164 , pp. 89-92
    • Han, M.1    Walsh, P.C.2    Partin, A.W.3    Rodriguez, R.4
  • 2
    • 0004747426 scopus 로고    scopus 로고
    • D'Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, Rhude M, Rocha S, Wein A, Richie JP. A validated system for predicting PSA outcome following radical prostatectomy in the PSA era: 10-year results. J Urol 2001 (in review).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.